Lung cancer remains a major global health challenge, and accurate pathological examination is crucial for early detection. This study aims to enhance hyperspectral pathological image analysis by refining annotations at the cell level and creating a high-quality hyperspectral dataset of lung tumors. We address the challenge of coarse manual annotations in hyperspectral lung cancer datasets, which limit the effectiveness of deep learning models requiring precise labels for training. We propose a semi-automated annotation refinement method that leverages hyperspectral data to enhance pathological diagnosis. Specifically, we employ K-means unsupervised clustering combined with human-guided selection to refine coarse annotations into cell-level masks based on spectral features. Our method is validated using a hyperspectral lung squamous cell carcinoma dataset containing 65 image samples. Experimental results demonstrate that our approach improves pixel-level segmentation accuracy from 77.33% to 92.52% with a lower level of prediction noise. The time required to accurately label each pathological slide is significantly reduced. While pixel-level labeling methods for an entire slide can take over 30 mins, our semi-automated method requires only about 5 mins. To enhance visualization for pathologists, we apply a conservative post-processing strategy for instance segmentation. These results highlight the effectiveness of our method in addressing annotation challenges and improving the accuracy of hyperspectral pathological analysis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11890753PMC
http://dx.doi.org/10.1038/s41598-025-85678-9DOI Listing

Publication Analysis

Top Keywords

lung cancer
12
annotation refinement
8
hyperspectral pathological
8
hyperspectral lung
8
hyperspectral
7
pathological
6
improving lung
4
cancer pathological
4
pathological hyperspectral
4
hyperspectral diagnosis
4

Similar Publications

Objectives: To assess the prognostic impact of adequate lymphadenectomy and determine the optimal nodal assessment for different clinical stages of lung cancer.

Methods: We retrospectively reviewed 1214 patients with clinical stage I-III non-small cell lung cancer who had preoperative PET/CT and curative surgery (2006-2017). Patients were categorized based on whether they had adequate [R0] or inadequate lymphadenectomy [R(un)].

View Article and Find Full Text PDF

Objectives: Compare oncologic outcomes between single-segment and multi-segment resections in patients with clinical stage IA1 and IA2 non-small cell lung cancer.

Methods: A retrospective review (2011-2022) was conducted using a prospectively maintained database. Patients undergoing anatomical segmentectomy for clinical stage IA ≤ 2 cm non-small cell lung cancers were included.

View Article and Find Full Text PDF

Lung cancer stands as the leading cause of cancer-related death worldwide, impacting both men and women in the United States and beyond. Radiation therapy (RT) serves as a key treatment modality for various lung malignancies. Our study aims to systematically assess the prognosis and influence of RT on metabolic reprogramming in patients diagnosed with nonsmall-cell lung cancer (NSCLC) through longitudinal metabolic profiling.

View Article and Find Full Text PDF

Lung cancer exhibits altered metabolism, influencing its response to radiation. To investigate the metabolic regulation of radiation response, we conducted a comprehensive, metabolic-wide CRISPR-Cas9 loss-of-function screen using radiation as selection pressure in human non-small cell lung cancer. Lipoylation emerged as a key metabolic target for radiosensitization, with lipoyltransferase 1 (LIPT1) identified as a top hit.

View Article and Find Full Text PDF

Intrabronchial delivery of therapeutic agents is critical to the treatment of respiratory diseases. Targeted delivery is demanded because of the off-target accumulation of drugs in normal lung tissues caused by inhalation and the limited motion dexterity of clinical bronchoscopes in tortuous bronchial trees. Herein, we developed microrobotic swarms consisting of magnetic hydrogel microparticles to achieve intrabronchial targeted delivery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!